THE TRULICITY 1.5 MG DIARIES

The trial accomplished both of those its Most important endpoints, with semaglutide 2.four mg demonstrating statistically significant and remarkable improvements in liver fibrosis without having worsening of steatohepatitis, and resolution of steatohepatitis with no worsening of liver fibrosis in people with MASH as compared to placebo.oneUnique Po